The Danish Competition and Consumer Authority approves Topdanmark A/S’ acquisition of Oona Health A/S

27 October 2023   

Announcement no. 15/2023   

The Danish Competition and Consumer Authority approves Topdanmark A/S’ acquisition of Oona Health A/S  

Today, the Danish Competition and Consumer Authority has unconditionally approved Topdanmark A/S’ acquisition of Oona Health A/S and all subsidiaries hereof from AnaCap. Thus, Topdanmark has received all relevant regulatory approvals to which the acquisition was subject as stated in the company announcement no. 04/2023 dated 16 March 2023.  

The transaction is expected to be completed as per 1 December 2023.  

As previously mentioned, the acquisition is expected to carry extraordinary costs related to the transaction of approx. DKK 100m. Of these, approx. DKK 30m will be recognised as an expense in Q4 2023. Topdanmark’s modelled profit forecast for 2023 of DKK 1,100-1,210m after tax, excluding run-off in Q4 2023, will be affected by the extraordinary costs recognised in Q4, all things equal. The expected premium growth is upgraded to above 2.5% whereas the expected combined ratio is maintained at 83.7-84.7 excluding run-off in Q4 2023. The profit forecast is based on standard assumptions for Q4 2023, including for weather-related and large-scale claims.   

Please direct any queries to:  

Lars Kufall Beck, CFO  

Direct tel: +45 44 74 30 28  

  

Robin Løfgren, Head of IR  

Direct tel.: +45 4474 4017, mobile tel.: +45 2962 1691  

  

Topdanmark A/S  
CVR no. 78040017  
Borupvang 4  
DK-2750 Ballerup  

Denmark